Economic Evaluation of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease

被引:284
|
作者
Fearon, William F. [1 ]
Bornschein, Bernhard [2 ]
Tonino, Pim A. L. [3 ]
Gothe, Raffaella M. [2 ]
De Bruyne, Bernard [4 ]
Pijls, Nico H. J. [3 ]
Siebert, Uwe [2 ,5 ]
机构
[1] Stanford Univ, Med Ctr, Div Cardiovasc Med, Stanford, CA 94305 USA
[2] Univ Hlth Sci Med Informat & Technol, Hall In Tirol, Austria
[3] Catharina Hosp, Eindhoven, Netherlands
[4] Cardiovasc Ctr Aalst, Aalst, Belgium
[5] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA
关键词
angiography; coronary disease; cost-benefit analysis; fractional flow reserve; myocardial; physiology; stents; COST-EFFECTIVENESS; ANGIOGRAPHY; STENOSIS;
D O I
10.1161/CIRCULATIONAHA.109.925396
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-The Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) study demonstrated significantly improved health outcomes at 1 year in patients randomized to multivessel percutaneous coronary intervention guided by fractional flow reserve (FFR) compared with percutaneous coronary intervention guided by angiography alone. The economic impact of routine measurement of FFR in this setting is not known. Methods and Results-In this study, 1005 patients were randomly assigned to FFR-guided or angiography-guided percutaneous coronary intervention and followed up for 1 year. A prospective cost-utility analysis comparing costs and quality-adjusted life-years was performed with a time horizon of 1 year. Quality-adjusted life-years were calculated with the use of utilities determined by the EuroQuol 5 dimension health survey with US weights. Direct medical costs included those of the index procedure and hospitalization and costs for major adverse cardiac events during follow-up. Confidence intervals for both quality-adjusted life-years and costs were estimated by the bootstrap percentile method. Major adverse cardiac events at 1 year occurred in 13.2% of those in the FFR-guided arm and 18.3% of those in the angiography-guided arm (P=0.02). Quality-adjusted life-years were slightly greater in the FFR-guided arm (0.853 versus 0.838; P=0.2). Mean overall costs at 1 year were significantly less in the FFR-guided arm ($14 315 versus $16 700; P<0.001). Bootstrap simulation indicated that the FFR-guided strategy was cost-saving in 90.74% and cost-effective at a threshold of US $50 000 per quality-adjusted life-years in 99.96%. Sensitivity analyses demonstrated robust results. Conclusion-Economic evaluation of the FAME study reveals that FFR-guided percutaneous coronary intervention in patients with multivessel coronary disease is one of those rare situations in which a new technology not only improves outcomes but also saves resources.
引用
收藏
页码:2545 / 2550
页数:6
相关论文
共 50 条
  • [1] Coronary Artery Bypass Grafting or Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Diabetic Patients With Multivessel Disease
    Di Gioia, Giuseppe
    Soto Flores, Nina
    Franco, Danilo
    Colaiori, Iginio
    Sonck, Jeroen
    Gigante, Carlo
    Kodeboina, Monika
    Bartunek, Jozef
    Vanderheyden, Marc
    Van Praet, Frank
    Casselman, Filip
    Degriek, Ivan
    Stockman, Bernard
    Barbato, Emanuele
    Collet, Carlos
    De Bruyne, Bernard
    [J]. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (10) : E009157
  • [2] IMPACT ANALYSES OF FRACTIONAL FLOW RESERVE-GUIDED PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH MULTIVESSEL DISEASE IN FRANCE AND BELGIUM
    Arvandi, M.
    Bornschein, B.
    Gothe, R. M.
    Rioufol, G.
    De Bruyne, B.
    De Pouvourville, G.
    Desmet, W.
    Lefevre, T.
    Fearon, W. F.
    Pijls, N. H. J.
    Siebert, U.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A246 - A246
  • [3] ECONOMIC EVALUATION OF FRACTIONAL FLOW RESERVE-GUIDED PERCUTANEOUS CORONARY INTERVENTION IN A DEVELOPING NATION
    Jimenez, Luis V. Martin
    Garcia, Carlos
    Cuevas, Diogenes
    Garcia, Paola
    Moya, Halley
    Herrera, Cesar
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 2131 - 2131
  • [4] Cost utility of fractional flow reserve-guided percutaneous coronary intervention in multivessel coronary artery disease in Brazil
    Stella, Steffan Frosi
    Polanczyk, Carisi Anne
    Arvandi, Marjan
    Siebert, Uwe
    [J]. INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, 2019, 31 (09) : 676 - 681
  • [5] Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease
    Berger, A
    Botman, KJ
    MacCarthy, PA
    Wijns, W
    Bartunek, J
    Heyndrickx, GR
    Pijls, NHJ
    De Bruyne, B
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (03) : 438 - 442
  • [6] The Impact of Sex Differences on Fractional Flow Reserve-Guided Percutaneous Coronary Intervention A FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) Substudy
    Kim, Hyun-Sook
    Tonino, Pim A. L.
    De Bruyne, Bernard
    Yong, Andy S. C.
    Tremmel, Jennifer A.
    Pijls, Nico H. J.
    Fearon, William F.
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2012, 5 (10) : 1037 - 1042
  • [7] The impact of age on fractional flow reserve-guided percutaneous coronary intervention: A FAME (Fractional Flow Reserve versus Angiography for Multivessel Evaluation) trial substudy
    Lim, Hong-Seok
    Tonino, Pim A. L.
    De Bruyne, Bernard
    Yong, Andy S. C.
    Lee, Bong-Ki
    Pijls, Nico H. J.
    Fearon, William F.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 177 (01) : 66 - 70
  • [8] Does Age Affect Fractional Flow Reserve-Guided Percutaneous Coronary Intervention? A FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) Trial Substudy
    Lim, Hong-Seok
    De Bruyne, Bernard
    Fearon, William F.
    Lee, Bong-Ki
    Pijls, Nico
    Tonino, Pim A.
    Yong, Andy S.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B25 - B25
  • [9] A protocol update of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 trial: A comparison of fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease
    Zimmermann, Frederik M.
    De Bruyne, Bernard
    Pijls, Nico H. J.
    Desai, Manisha
    Oldroyd, Keith G.
    Reardon, Michael J.
    Wendler, Olaf
    Woo, Joseph
    Yeung, Alan C.
    Fearon, William F.
    [J]. AMERICAN HEART JOURNAL, 2019, 214 : 156 - 157
  • [10] Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: A comparison of fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease
    Zimmermann, Frederik M.
    De Bruyne, Bernard
    Pijls, Nico H. J.
    Desai, Manisha
    Oldroyd, Keith G.
    Park, Seung-Jung
    Reardon, Michael J.
    Wendler, Olaf
    Woo, Joseph
    Yeung, Alan C.
    Fearon, William F.
    [J]. AMERICAN HEART JOURNAL, 2015, 170 (04) : 619 - +